MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+57.24%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$245M
AUM Growth
+$245M
(+20%)
Cap. Flow
-$46.1M
Cap. Flow
% of AUM
-18.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Dyne Therapeutics
DYN
|
$42.6M |
| 2 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$3.56M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Dyne Therapeutics
DYN
$1.92B
| $98M | 39.97% | 3,451,303 -1,500,000 | -30% | -$42.6M |
|
2
Entrada Therapeutics
TRDA
$208M
| $62.7M | 25.58% | 4,425,784 | – | – |
|
3
iTeos Therapeutics
ITOS
| $37.4M | 15.24% | 2,738,785 | – | – |
|
4
Werewolf Therapeutics
HOWL
$59.9M
| $27.8M | 11.32% | 4,284,172 | – | – |
|
5
Repare Therapeutics
RPTX
$71.7M
| $10.6M | 4.31% | 2,242,636 | – | – |
|
|
ADAP
6
Adaptimmune Therapeutics
ADAP
$15.6M
| $8.78M | 3.58% | 5,555,461 | – | – |
|
|
HARP
7
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| – | – | -313,136 | Closed | -$3.56M |
|